Interassay Correlation of Human Herpesvirus 8 Serologic Tests

To standardize human herpesvirus 8 (HHV-8) antibody assays for application to asymptomatic infection, a blinded comparison was done of seven immunofluorescence assays and ELISAs. Five experienced laboratories tested a serum panel from 143 subjects in 4 diagnostic groups. Except for a minor capsid pr...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 178; no. 2; pp. 304 - 309
Main Authors Rabkin, Charles S., Schulz, Thomas F., Whitby, Denise, Lennette, Evelyne T., Magpantay, Larry I., Chatlynne, Louise, Biggar, Robert J.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.08.1998
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text
ISSN0022-1899
1537-6613
DOI10.1086/515649

Cover

More Information
Summary:To standardize human herpesvirus 8 (HHV-8) antibody assays for application to asymptomatic infection, a blinded comparison was done of seven immunofluorescence assays and ELISAs. Five experienced laboratories tested a serum panel from 143 subjects in 4 diagnostic groups. Except for a minor capsid protein ELISA, the other six tests detected HHV-8 antibodies most frequently in classic (80%–100%) and AIDS-related (67%–91%) Kaposi's sarcoma, followed by human immunodeficiency virus-seropositive patients (27%–60%), and least frequently in healthy blood donors (0–29%). However, these six assays frequently disagreed on individual sera, particularly for blood donor samples. Current HHV-8 antibody tests have uncertain accuracy in asymptomatic HHV-8 infection and may require correlation with viral protein or nucleic acid detection. Antibody assays are useful for epidemiologic investigations, but the absolute prevalence of HHV-8 infection in the United States cannot yet be determined.
Bibliography:Reprints or correspondence: Dr. Charles S. Rabkin, Viral Epidemiology Branch, NCI, 6130 Executive Blvd., EPN/434, Rockville, MD 20852.
istex:4FF1B8AFFCF2F0A37D84047CCC67DBE75CFA5AFB
ark:/67375/HXZ-LK36B9VW-H
Presented in part: 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 22–26 January 1997 (abstract 699).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1086/515649